19-4324629-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_017720.3(STAP2):​c.1111G>A​(p.Glu371Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000429 in 1,236,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

STAP2
NM_017720.3 missense

Scores

13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.29
Variant links:
Genes affected
STAP2 (HGNC:30430): (signal transducing adaptor family member 2) This gene encodes the substrate of breast tumor kinase, an Src-type non-receptor tyrosine kinase. The encoded protein possesses domains and several tyrosine phosphorylation sites characteristic of adaptor proteins that mediate the interactions linking proteins involved in signal transduction pathways. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.053706706).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAP2NM_001013841.2 linkc.1073-100G>A intron_variant Intron 11 of 12 ENST00000594605.6 NP_001013863.1 Q9UGK3-1
STAP2NM_017720.3 linkc.1111G>A p.Glu371Lys missense_variant Exon 12 of 13 NP_060190.2 Q9UGK3-2
STAP2XM_011528123.2 linkc.1108G>A p.Glu370Lys missense_variant Exon 12 of 13 XP_011526425.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAP2ENST00000594605.6 linkc.1073-100G>A intron_variant Intron 11 of 12 1 NM_001013841.2 ENSP00000471052.1 Q9UGK3-1

Frequencies

GnomAD3 genomes
AF:
0.0000199
AC:
3
AN:
151030
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000147
AC:
2
AN:
136086
Hom.:
0
AF XY:
0.0000137
AC XY:
1
AN XY:
72736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000488
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000193
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000461
AC:
50
AN:
1084986
Hom.:
0
Cov.:
14
AF XY:
0.0000405
AC XY:
22
AN XY:
543210
show subpopulations
Gnomad4 AFR exome
AF:
0.0000788
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000450
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000126
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000410
Gnomad4 OTH exome
AF:
0.000107
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151144
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
73836
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000195
Gnomad4 SAS
AF:
0.000209
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
ExAC
AF:
0.0000166
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 24, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1111G>A (p.E371K) alteration is located in exon 12 (coding exon 12) of the STAP2 gene. This alteration results from a G to A substitution at nucleotide position 1111, causing the glutamic acid (E) at amino acid position 371 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.40
DANN
Benign
0.43
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.00064
N
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.0024
T
MetaRNN
Benign
0.054
T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.44
T
Sift4G
Benign
0.71
T
Polyphen
0.0
B
Vest4
0.13
MutPred
0.38
Gain of ubiquitination at E371 (P = 0.0045);
MVP
0.13
MPC
0.30
ClinPred
0.028
T
GERP RS
-0.77
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs771729090; hg19: chr19-4324626; API